• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导性共刺激分子(ICOS)共刺激需要白细胞介素-2(IL-2),并且可以通过细胞毒性T淋巴细胞相关蛋白4(CTLA-4)的结合来阻止。

ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.

作者信息

Riley J L, Blair P J, Musser J T, Abe R, Tezuka K, Tsuji T, June C H

机构信息

Abramson Family Cancer Research Institute and Department of Molecular and Cellular Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

J Immunol. 2001 Apr 15;166(8):4943-8. doi: 10.4049/jimmunol.166.8.4943.

DOI:10.4049/jimmunol.166.8.4943
PMID:11290772
Abstract

We investigated the relationship between ICOS, CD28, CTLA-4, and IL-2 to gain a better understanding of this family of costimulatory receptors in the immune response. Using magnetic beads coated with anti-CD3 and varying amounts of anti-ICOS and anti-CTLA-4 Abs, we show that CTLA-4 ligation blocks ICOS costimulation. In addition to inhibiting cellular proliferation, CTLA-4 engagement prevented ICOS-costimulated T cells from producing IL-4, IL-10, and IL-13. Both an indirect and direct mechanism of CTLA-4's actions were examined. First, CTLA-4 engagement on resting cells was found to indirectly block ICOS costimulation by interferring with the signals needed to induce ICOS cell surface expression. Second, on preactivated cells that had high levels of ICOS expression, CTLA-4 ligation blocked the ICOS-mediated induction of IL-4, IL-10, and IL-13, suggesting an interference with downstream signaling pathways. The addition of IL-2 not only overcame both mechanisms, but also greatly augmented the level of cellular activation suggesting synergy between ICOS and IL-2 signaling. This cooperation between ICOS and IL-2 signaling was explored further by showing that the minimum level of IL-2 produced by ICOS costimulation was required for T cell proliferation. Finally, exogenous IL-2 was required for sustained growth of ICOS-costimulated T cells. These results indicate that stringent control of ICOS costimulation is maintained initially by CTLA-4 engagement and later by a requirement for exogenous IL-2.

摘要

我们研究了诱导共刺激分子(ICOS)、细胞毒性T淋巴细胞相关抗原4(CTLA-4)、CD28和白细胞介素-2(IL-2)之间的关系,以便更好地理解免疫反应中这一族共刺激受体。使用包被抗CD3以及不同量抗ICOS和抗CTLA-4抗体的磁珠,我们发现CTLA-4的结合会阻断ICOS共刺激。除了抑制细胞增殖外,CTLA-4的结合还阻止了ICOS共刺激的T细胞产生IL-4、IL-10和IL-13。我们研究了CTLA-4作用的间接和直接机制。首先,发现静止细胞上CTLA-4的结合通过干扰诱导ICOS细胞表面表达所需的信号间接阻断ICOS共刺激。其次,在ICOS表达水平高的预激活细胞上,CTLA-4的结合阻断了ICOS介导的IL-4、IL-10和IL-13的诱导,提示对下游信号通路的干扰。IL-2的添加不仅克服了这两种机制,还极大地增强了细胞激活水平,提示ICOS和IL-2信号之间存在协同作用。通过显示ICOS共刺激产生的IL-2的最低水平是T细胞增殖所必需的,进一步探索了ICOS和IL-2信号之间的这种合作。最后,ICOS共刺激的T细胞持续生长需要外源性IL-2。这些结果表明,ICOS共刺激的严格控制最初通过CTLA-4的结合来维持,随后通过对外源性IL-2的需求来维持。

相似文献

1
ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.诱导性共刺激分子(ICOS)共刺激需要白细胞介素-2(IL-2),并且可以通过细胞毒性T淋巴细胞相关蛋白4(CTLA-4)的结合来阻止。
J Immunol. 2001 Apr 15;166(8):4943-8. doi: 10.4049/jimmunol.166.8.4943.
2
Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.前沿:相关分子CD28和诱导性共刺激分子传递最佳T细胞活化所需的独特且互补的信号。
J Immunol. 2001 Jan 1;166(1):1-5. doi: 10.4049/jimmunol.166.1.1.
3
Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.TCR激活时程序性死亡-1的参与对共刺激和细胞因子驱动的增殖有不同影响:ICOS、IL-4和IL-21反应减弱,但CD28、IL-7和IL-15反应不受影响。
J Immunol. 2003 Jan 15;170(2):711-8. doi: 10.4049/jimmunol.170.2.711.
4
Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.通过CTLA-4共刺激使初始CD4+ T细胞向Th1亚群极化。
J Immunol. 2000 Apr 1;164(7):3554-62. doi: 10.4049/jimmunol.164.7.3554.
5
Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.小鼠诱导性共刺激分子(ICOS)的表达通过CD28共刺激得以增强,并调节CD4+ T细胞的分化。
J Immunol. 2000 Nov 1;165(9):5035-40. doi: 10.4049/jimmunol.165.9.5035.
6
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.细胞毒性T淋巴细胞相关抗原4(CTLA-4,即CD152)可通过两种不同机制抑制T细胞活化,具体取决于其细胞表面表达水平。
J Immunol. 2000 Aug 1;165(3):1352-6. doi: 10.4049/jimmunol.165.3.1352.
7
CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.CD28和诱导性共刺激蛋白Src同源2结合结构域在原代人CD4 T淋巴细胞中对磷脂酰肌醇3激酶、Bcl-xL和白细胞介素-2的表达显示出不同的调控作用。
J Immunol. 2003 Jul 1;171(1):166-74. doi: 10.4049/jimmunol.171.1.166.
8
PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.在AILIM/ICOS和CD28共刺激的T细胞中,PI3激酶和MAP激酶信号级联在细胞增殖和白细胞介素-10产生之间具有不同的功能。
Biochem Biophys Res Commun. 2003 Oct 24;310(3):691-702. doi: 10.1016/j.bbrc.2003.09.065.
9
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.CTLA-4与CD28在活化T淋巴细胞上的共表达及功能协同作用。
J Exp Med. 1992 Dec 1;176(6):1595-604. doi: 10.1084/jem.176.6.1595.
10
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.与CD28相关的分子ICOS:在有和没有B7.1/2情况下的T细胞调节以及在多发性硬化症中的调节性表达
J Neuroimmunol. 2003 Jul;140(1-2):177-87. doi: 10.1016/s0165-5728(03)00172-3.

引用本文的文献

1
Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer.程序性死亡受体1(PD-1)抑制剂对晚期恶性黑色素瘤和非小细胞肺癌患者外周循环免疫亚群的早期影响
BMC Cancer. 2024 Dec 30;24(1):1590. doi: 10.1186/s12885-024-13351-x.
2
Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy.直面免疫治疗领域的棘手问题:抗CTLA-4疗法对效应T细胞启动与调节性T细胞耗竭的影响
Cancers (Basel). 2022 Mar 20;14(6):1580. doi: 10.3390/cancers14061580.
3
Inducible T-Cell Costimulator Ligand Plays a Dual Role in Melanoma Metastasis upon Binding to Osteopontin or Inducible T-Cell Costimulator.
诱导性T细胞共刺激配体在与骨桥蛋白或诱导性T细胞共刺激分子结合后,在黑色素瘤转移中发挥双重作用。
Biomedicines. 2021 Dec 27;10(1):51. doi: 10.3390/biomedicines10010051.
4
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.阿卡西考普特(ALPN-101),一种双重 ICOS/CD28 拮抗剂,在系统性硬化症的临床前小鼠模型中显示出疗效。
Arthritis Res Ther. 2022 Jan 5;24(1):13. doi: 10.1186/s13075-021-02709-2.
5
Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis.攻克乳腺癌的免疫靶点:超越PD-1/PD-L1轴
Front Oncol. 2021 Mar 5;11:628138. doi: 10.3389/fonc.2021.628138. eCollection 2021.
6
T cell costimulation, checkpoint inhibitors and anti-tumor therapy.T 细胞共刺激、检查点抑制剂和抗肿瘤治疗。
J Biosci. 2020;45.
7
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma.抗CD40单克隆抗体增强了抗PD-1治疗骨肉瘤的疗效。
J Bone Oncol. 2019 Jun 12;17:100245. doi: 10.1016/j.jbo.2019.100245. eCollection 2019 Aug.
8
Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model.在灵长类心脏移植模型中,用αCD40进行延迟性ICOS/ICOS-L阻断以调节致病性同种异体免疫的初步研究。
Transplant Direct. 2018 Feb 2;4(2):e344. doi: 10.1097/TXD.0000000000000761. eCollection 2018 Feb.
9
Signals that drive T follicular helper cell formation.驱动滤泡辅助性T细胞形成的信号。
Immunology. 2017 Oct;152(2):185-194. doi: 10.1111/imm.12778. Epub 2017 Jul 17.
10
Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression.通过选择性阻断CD28抑制供体反应性CD8 + T细胞反应与ICOS表达降低无关。
PLoS One. 2015 Jun 22;10(6):e0130490. doi: 10.1371/journal.pone.0130490. eCollection 2015.